News By Tag Industry News News By Location Country(s) Industry News
| Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific HybridizationCreative Peptides rolls out a variety of PNA FISH probe products with high sensitivity and specific hybridization for worldwide customers.
Fluorescence in situ hybridization (FISH) is a cytogenetic method to detect and target the presence or absence of specific DNA sequences on chromosomes. Peptide nucleic acid (PNA) is a synthetic polymer similar to DNA or RNA. Its high binding strength and great specific hybridization add scientific appeal to researchers. And the probes, which can be RNA, DNA, or oligonucleotide sequence, are applied to detect the expression of a specific gene or transcription product. PNA probes are widely used in the fields of genetically modified testing, microbial and Yersinia pestis detection, as well as disease diagnosis. Creative Peptides developed different PNA probes targeted to specific research purposes. For instance, telomere PNA probes can conduct qualitative and quantitative analyses of repeated telomere sequences. Centromeric PNA probes can identify the centromeric region of each chromosome and detect the numerical analyses of chromosomes. Therefore, it's convenient for clients to choose the probe products they need. Creative Peptides' PNA FISH probe products enjoy many advantages. On the one hand, PNA probes possess a powerful specific hybridization capability (https://pna.creative- "Creative Peptides has been engaged in PNA for decades and developed a series of PNA products and services for customers. The PNA FISH probes have been rigorously validated and examined to enable high sensitivity." About Creative Peptides For decades, Creative Peptides has been the leader in peptide nucleic acid research in the United States. Peptides at current can serve a full range of high-quality products and comprehensive services in a wide range of markets including PNA design, PNA-based biochemical services, custom synthesis, chemical modification, and drug development services. End
|
|